FDA Authorizes First Wearable Device That Continuously Monitors Both Ketone Levels and Blood Sugar
RegulatoryapprovedLibre Duo 10 Day Continuous Dual Glucose Ketone Monitoring SystemPositive
AI Analysis
Summary
The FDA authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, the first wearable device that simultaneously monitors both ketone and blood sugar levels, for patients aged 2 years and older with diabetes.
Outcome Details
FDA authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System
Importance:8/10
Sentiment:
0.80
FDA approvalwearable devicediabetescontinuous monitoringglucoseketone
Related Companies
Read the original article
Published by FDA Press Releases on August 25, 2026 6:21 PM